SILVER SPRING, Md. — The U.S. Food and Drug Administration has issued an official drug safety communication regarding the development of uncontrollable gambling, eating, shopping, and sexual behaviors in those prescribed to Abilify, according to The Wall Street Journal.
The drug, also known as Ariprazole, is manufactured by Otsuka Pharmaceutical Co. and Alkermes PLC.
Since Abilify was approved for use in the United States by the FDA in 2002, 184 cases of impulsive behavior side effects have been reported. Despite reported side effects, however, the drug is still immensely popular with 1.6 million prescriptions being issued in 2015.
The FDA report claims the uncontrollable urges subside when the drug is no longer taken or when the dosage is adjusted.
The agency went on to warn patients and caregivers to be aware of the risks associated with Abilify and of identifying signs of these uncontrollable behaviors.
Our Abilify Lawyers Can Help You
Our dangerous drug lawyers can help if you or someone you care about was harmed as a result of taking Abilify. Lawsuits have been filed against the drug manufacturer for allegedly downplaying this risk information. Both patients and their families are seeking compensation for injuries. You may be entitled to a settlement if you were harmed by Abilify.
Our No-Fee Promise On Abilify Cases
You can afford to have our great team of Abilify lawyers on your side. If you choose us, it literally costs you nothing to get started. We promise you in writing:
- No money to get started
- We pay all case costs and expenses
- No legal fees whatsoever unless you receive an Abilify settlement
- Phone calls are always free
Start Your Abilify Claim
Our Abilify drug lawyers will help you file your lawsuit. To get started, you can:
- Submit the Free Case Review Box on this page, or
- Call (866) 280-4722 any time of day to tell us about your case.
We will listen to your story and answer your questions. If you have a claim, we will start immediately.
WARNING: There are strict time deadlines for filing Abilify lawsuit claims.